Karma Research Team

The Karma Research Team writes plain-language summaries of published preclinical and laboratory research on the peptides and research compounds we supply. Articles draw on peer-reviewed literature and are checked against our Research Use Only policy before publishing. We do not provide medical advice or guidance on dosing or human use.

KPV Peptide: Mechanisms, Research Applications, and Evidence

Compound Profiles / Karma Research Team

Quick answer: KPV (Lys-Pro-Val) is a tripeptide taken from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Preclinical studies, mostly in cell culture and rodents, show it reduces inflammatory signaling, largely by inhibiting NF-kB, and it has been studied in gut, skin and wound-healing models. Human evidence is limited, and it is supplied for research use […]

KPV Peptide: Mechanisms, Research Applications, and Evidence Read More »